Abstract
PRADER-WILLI syndrome (PWS) is the most common form of dysmorphic genetic obesity associated with mental retardation1,2. About 60% of cases have a cytological deletion of chromosome 15q11q13 (refs 2, 3). These deletions occur de novo exclusively on the paternal chromosome4,5. By contrast, Angelman syndrome (AS) is a very different clinical disorder and is also associated with deletions of region 15q11q13 (refs 6–8), indistinguishable from those in PWS6,8 except that they occur de novo on the maternal chromosome6. The parental origin of the affected chromosomes 15 in these disorders could, therefore, be a contributory factor in determining their clinical phenotypes. We have now used cloned DNA markers specific for the 15q11q13 subregion5,9,10 to determine the parental origin of chromosome 15 in PWS individuals not having cytogenetic deletions; these individuals account for almost all of the remaining 40% of PWS cases. Probands in two families displayed maternal uniparental disomy for chromosome 15q11q13. This is the first demonstration that maternal heterodisomy—the presence of two different chromosome 15s derived from the mother—can be associated with a human genetic disease. The absence of a paternal contribution of genes in region 15q11q13, as found in PWS deletion cases4,5, rather than a mutation in a specific gene(s) in this region may result in expression of the clinical phenotype. Thus, we conclude that a gene or genes in region 15q11q13 must be inherited from each parent for normal human development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cassidy, S. B. Curr. Problems Pediatr. 14, 1–55 (1984).
Butler, M. G. Am. J. med. Genet. (in the press).
Ledbetter, D. H., Greenberg, F., Holm, V. A. & Cassidy, S. B. Am. J. med. Genet. 28, 779–790 (1987).
Butler, M. G., Meaney, F. J. & Palmer, C. G. Am. J. med. Genet. 23, 793–809 (1986).
Nicholls, R. D. et al. Am. J. med. Genet. 33, 66–77 (1989).
Knoll, J. H. M. et al. Am. J. med. Genet. 32, 285–290 (1989).
Pembrey, M. et al. J. Med. Genet. 26, 73–77 (1989).
Donlon, T. A. Hum. Genet. 80, 322–328 (1988).
Donlon, T. A., Lalande, M., Wyman, A., Bruns, G. & Latt, S. A. Proc. natn. Acad. Sci. U.S.A. 83, 4408–4412 (1986).
Tantravahi, U. et al. Am. J. med. Genet. 33, 78–87 (1989).
Rich, D. C., Witkowski, C. M., Summers, K. M., van Tuinen, P. & Ledbetter, D. H. Nucleic Acids Res. 16, 8740 (1988).
Higgs, D. R. et al. Proc. natn. Acad. Sci. U.S.A. 83, 5165–5169 (1986).
Butler, M. G. & Meaney, F. J. Am. J. med. Genet. 26, 445–455 (1987).
Butler, M. G. Am. J. hum. Genet. 45, 140–146 (1989).
Engel, E. Am. J. med. Genet. 6, 137–143 (1980).
Spence, J. E. et al. Am. J. hum. Genet. 42, 217–226 (1988).
Warburton, D. Am. J. hum. Genet. 42, 215–216 (1988).
Solter, D. A. Rev. Genet. 22, 127–146 (1988).
Sapienza, C. Annls N. Y. Acad. Sci. (in the press).
Monk, M. Genes Dev. 2, 921–925 (1988).
Holliday, R. Sci. Am. 260, 60–73 (1989).
Surani, M. A., Reik, W. & Allen, N. D. Trends Genet. 4, 59–62 (1988).
Cedar, H. Cell 53, 3–4 (1988).
Kajii, T. & Ohama, K. Nature 268, 633–634 (1977).
Reik, W. J. med. Genet. 25, 805–808 (1988).
Reik, W. & Surani, M. A. Nature 338, 112–113 (1989).
Scrable, H. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Voss, R. et al. Am. J. hum. Genet. 45, 373–380 (1989).
Yunis, J. J. Science 191, 1268–1270 (1976).
Seabright, M. Lancet ii, 971–972 (1971).
Lalande, M. et al. Cancer Genet. Cytogenet. 13, 283–295 (1984).
Fischel-Ghodsian, N., Nicholls, R. D. & Higgs, D. R. Nucleic. Acids Res. 15, 6197–6207 (1987).
Lalande, M., Noolandi, J., Turmel, C., Rousseau, J. & Slater, G. W. Proc. natn. Acad. Sci. U.S.A. 84, 8011–8015 (1987).
Schwartz, D. C. & Cantor, C. R. Cell 37, 67–75 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nicholls, R., Knoll, J., Butler, M. et al. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome. Nature 342, 281–285 (1989). https://doi.org/10.1038/342281a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/342281a0
This article is cited by
-
Novel epigenetic molecular therapies for imprinting disorders
Molecular Psychiatry (2023)
-
The dominant findings of a recessive man: from Mendel’s kid pea to kidney
Pediatric Nephrology (2023)
-
Prader-Willi syndrome patient with atypical phenotypes caused by mosaic deletion in the paternal 15q11-q13 region: a case report
Italian Journal of Pediatrics (2022)
-
Promising therapeutic aspects in human genetic imprinting disorders
Clinical Epigenetics (2022)
-
The contribution of imprinted genes to neurodevelopmental and neuropsychiatric disorders
Translational Psychiatry (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.